HRP20080057T3 - 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof - Google Patents

9,10-alpha,alpha-oh-taxane analogs and methods for production thereof

Info

Publication number
HRP20080057T3
HRP20080057T3 HR20080057T HRP20080057T HRP20080057T3 HR P20080057 T3 HRP20080057 T3 HR P20080057T3 HR 20080057 T HR20080057 T HR 20080057T HR P20080057 T HRP20080057 T HR P20080057T HR P20080057 T3 HRP20080057 T3 HR P20080057T3
Authority
HR
Croatia
Prior art keywords
alpha
group
hydroxyl
methods
present
Prior art date
Application number
HR20080057T
Other languages
English (en)
Croatian (hr)
Inventor
D. Mcchesney James
Ferrara James
Zygmut Jan
Original Assignee
Tapestry Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tapestry Pharmaceuticals filed Critical Tapestry Pharmaceuticals
Publication of HRP20080057T3 publication Critical patent/HRP20080057T3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HR20080057T 2003-09-25 2008-02-05 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof HRP20080057T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25
PCT/US2004/031816 WO2005030150A2 (en) 2003-09-25 2004-09-27 9,10-α,α-OH-TAXANE ANALOGS AND METHODS FOR PRODUCTION THEREOF

Publications (1)

Publication Number Publication Date
HRP20080057T3 true HRP20080057T3 (en) 2008-02-29

Family

ID=34393186

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080057T HRP20080057T3 (en) 2003-09-25 2008-02-05 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof

Country Status (14)

Country Link
US (8) US7745650B2 (de)
EP (2) EP1664033B1 (de)
JP (5) JP4874102B2 (de)
CN (1) CN1886400A (de)
AT (1) ATE377593T1 (de)
AU (1) AU2004275881A1 (de)
CA (1) CA2539975C (de)
DE (1) DE602004009943T2 (de)
DK (1) DK1664033T3 (de)
ES (1) ES2295937T3 (de)
HR (1) HRP20080057T3 (de)
PL (1) PL1664033T3 (de)
PT (1) PT1664033E (de)
WO (1) WO2005030150A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE377593T1 (de) 2003-09-25 2007-11-15 Tapestry Pharmaceuticals Inc 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung
JP2008536479A (ja) 2005-02-11 2008-09-11 ユニバーシティ オブ サザン カリフォルニア ジスルフィド架橋を有するタンパク質の発現法
US20100069643A1 (en) * 2005-12-21 2010-03-18 Mcchesney James D Convergent Process for the Synthesis of Taxane Derivatives
EP1973892A1 (de) * 2005-12-21 2008-10-01 Tapestry Pharmaceuticals, Inc. Neue verbindungen und verfahren zur bildung von taxanen und verwendung davon
RU2008142363A (ru) * 2006-03-27 2010-05-10 Тэпистри Фармасьютикалз, Инк. (Us) Конвергентный способ синтеза таксановых производных
US8008256B2 (en) * 2006-05-01 2011-08-30 University Of Southern California Combination therapy for treatment of cancer
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
EP2029563A4 (de) * 2006-06-12 2009-12-02 Canada Inc 6570763 Halbsynthetische route zur herstellung von paclitaxel, docetaxel und 10-deacetylbaccatin iii aus 9-dihydro-13-acetylbaccatin iii
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
CN103764138A (zh) * 2011-04-07 2014-04-30 阿伯疗法责任有限公司 紫杉烷和Abeo-紫杉烷类似物
KR101444693B1 (ko) * 2011-06-06 2014-09-26 아버 테라퓨틱스 엘엘씨 암 화학요법제의 산에 불안정한 친유성 전구약물

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
ATE181551T1 (de) 1992-04-17 1999-07-15 Abbott Lab Taxol-derivate
FR2697019B1 (fr) 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
ATE249826T1 (de) * 1992-11-13 2003-10-15 Univ Florida State Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen
DK0688212T3 (da) * 1993-03-05 2002-10-07 Univ Florida State C9-taxanderivater og farmaceutiske præparater indeholdende disse
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
DE69432140T2 (de) 1993-03-05 2003-07-31 Univ Florida State Verfahren zur Herstellung von 9-Desoxotaxanen
EP0689436B1 (de) * 1993-03-22 2003-11-26 Florida State University Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate
FR2707293A1 (fr) * 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
JP2003521514A (ja) * 2000-02-02 2003-07-15 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc10ヘテロ置換アセテートタキサン
WO2002076448A1 (en) 2001-03-23 2002-10-03 Napro Biotherapeutics, Inc. Molecular conjugates for use in treatment of cancer
CA2354471A1 (en) 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
HUP0500843A2 (hu) 2001-12-20 2005-12-28 Bristol-Myers Squibb Co., Fokozott biológiai hasznosulású, szájon át hatásos taxánszármazékokat tartalmazó gyógyszerkészítmények
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
EP1894921A3 (de) 2003-09-25 2008-03-12 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-OH-Taxan-Analoga und Herstellungsverfahren dafür
ATE377593T1 (de) 2003-09-25 2007-11-15 Tapestry Pharmaceuticals Inc 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung
US20090246211A1 (en) 2005-05-12 2009-10-01 Henri John T Molecular constructs suitable for targeted conjugates
EP1973892A1 (de) 2005-12-21 2008-10-01 Tapestry Pharmaceuticals, Inc. Neue verbindungen und verfahren zur bildung von taxanen und verwendung davon
US20100069643A1 (en) 2005-12-21 2010-03-18 Mcchesney James D Convergent Process for the Synthesis of Taxane Derivatives
RU2008142363A (ru) 2006-03-27 2010-05-10 Тэпистри Фармасьютикалз, Инк. (Us) Конвергентный способ синтеза таксановых производных
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment

Also Published As

Publication number Publication date
JP4874102B2 (ja) 2012-02-15
US7879904B2 (en) 2011-02-01
US8962870B2 (en) 2015-02-24
EP1664033A4 (de) 2006-09-13
EP1785416A3 (de) 2007-05-30
PT1664033E (pt) 2008-01-17
EP1664033B1 (de) 2007-11-07
EP1785416A2 (de) 2007-05-16
US20200237708A1 (en) 2020-07-30
DE602004009943T2 (de) 2008-08-28
US20120077871A1 (en) 2012-03-29
US10639293B2 (en) 2020-05-05
US9402824B2 (en) 2016-08-02
US20190142784A1 (en) 2019-05-16
ATE377593T1 (de) 2007-11-15
US20180125811A1 (en) 2018-05-10
JP5629632B2 (ja) 2014-11-26
DK1664033T3 (da) 2008-03-25
ES2295937T3 (es) 2008-04-16
AU2004275881A1 (en) 2005-04-07
US9820962B2 (en) 2017-11-21
US20160331718A1 (en) 2016-11-17
WO2005030150A3 (en) 2005-07-14
JP2011012070A (ja) 2011-01-20
US7745650B2 (en) 2010-06-29
DE602004009943D1 (de) 2007-12-20
JP6216417B2 (ja) 2017-10-18
PL1664033T3 (pl) 2008-04-30
CA2539975C (en) 2012-11-20
CN1886400A (zh) 2006-12-27
JP2014196345A (ja) 2014-10-16
US10238621B2 (en) 2019-03-26
WO2005030150A2 (en) 2005-04-07
US20100324128A1 (en) 2010-12-23
JP6106634B2 (ja) 2017-04-05
CA2539975A1 (en) 2005-04-07
JP2007506792A (ja) 2007-03-22
JP2011137045A (ja) 2011-07-14
JP5525394B2 (ja) 2014-06-18
EP1664033A2 (de) 2006-06-07
US20050148657A1 (en) 2005-07-07
JP2016180006A (ja) 2016-10-13
US20150133536A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
HUP0302755A2 (hu) Eljárás kamptotecin-analóg vegyületek előállítására
EP1262469A4 (de) Polyacen-derivate und ihre produktion
ATE527270T1 (de) Herstellung von organosilanestern
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
DE50308114D1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)-dibenz(c,e)(1,2)-oxaphosphorinen
EP1810968A3 (de) 9, 10-a, a-OH-Taxan-Analoge und Herstellungsverfahren dafür
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
ATE523198T1 (de) Pyrroloä2,3-düpyrimidine zur behandlung von krebs durch mitosehemmung
DE69616719T2 (de) Verfahren zur herstellung von taxol und seiner derivate
DE602004014769D1 (de) Reaktive flammschutzmittel und flammgeschützte harzprodukte
NZ335105A (en) Process for alkylating hindered sulfonamides
ATE223414T1 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
EP1022269A3 (de) Sulfoniumsalze und Verfahren zur Herstellung
MEP1708A (xx) Postupak proizvodnje thip-a
TW200720282A (en) Novel organosilicon compound and process for producing the same
ATE325159T1 (de) Verfahren zur herstellung von synergistischen stabilisatorgemischen
ATE553081T1 (de) Verfahren zur herstellung einer bakteriziden pyridinverbindung, und bakterizide pyridinverbindung
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
IL166696A (en) Process for producing gamma-ketoacetal compounds
PT102935B (de)
HK1114084A1 (en) Method for producing thiocarbamate derivative
GEP20074217B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
ATE492556T1 (de) Verfahren zur glycosidierung von colchicin und thiocolchicin
DE602004029888D1 (en) Hydroxycarbonylphenyl substituierte 4-(aminomethyl)-piperidinbenzamide als 5ht4-antagonisten